Westwood Holdings Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,848
Closed -$802K 569
2022
Q4
$802K Sell
11,848
-1,560
-12% -$91.5K 0.01% 370
2022
Q3
$668K Sell
13,408
-10,494
-44% -$562K 0.01% 347
2022
Q2
$1.33M Sell
23,902
-150
-0.6% -$8.32K 0.01% 319
2022
Q1
$1.33M Sell
24,052
-2,512
-9% -$129K 0.01% 337
2021
Q4
$1.49M Buy
26,564
+11,452
+76% +$620K 0.01% 320
2021
Q3
$725K Sell
15,112
-1,140
-7% -$55.1K 0.01% 359
2021
Q2
$681K Sell
16,252
-6,794
-29% -$263K 0.01% 369
2021
Q1
$777K Sell
23,046
-2,058
-8% -$73.3K 0.01% 357
2020
Q4
$877K Sell
25,104
-4,266
-15% -$147K 0.01% 341
2020
Q3
$1.02M Sell
29,370
-1,938
-6% -$64.6K 0.01% 315
2020
Q2
$1.02M Sell
31,308
-27,102
-46% -$865K 0.01% 325
2020
Q1
$1.76M Sell
58,410
-25,606
-30% -$762K 0.03% 276
2019
Q4
$2.43M Sell
84,016
-984
-1% -$27.2K 0.03% 295
2019
Q3
$2.2M Sell
85,000
-4,144
-5% -$105K 0.02% 291
2019
Q2
$2.27M Sell
89,144
-4,986
-5% -$123K 0.02% 299
2019
Q1
$2.46M Buy
94,130
+63,298
+205% +$1.56M 0.03% 256
2018
Q4
$710K Sell
30,832
-66,228
-68% -$1.47M 0.01% 319
2018
Q3
$2.29M Sell
97,060
-11,270
-10% -$275K 0.02% 265
2018
Q2
$2.5M Sell
108,330
-4,410
-4% -$105K 0.02% 270
2018
Q1
$2.78M Buy
+112,740
New +$2.96M 0.02% 271

Other funds holding NVO

Westwood Holdings Group's NVO Position: Q1 2023 in Review

Westwood Holdings Group sold out of Novo Nordisk (NVO) in Q1 2023, closing a stake of 11,848 shares — an estimated $802K sold.

Westwood Holdings Group first reported a position in NVO in Q1 2018 and held it in 20 quarters. The position peaked at $2.78M in Q1 2018. 1,146 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • Westwood Holdings Group reported no remaining Novo Nordisk position as of Q1 2023 after selling out during the quarter.
  • Westwood Holdings Group sold 11,848 Novo Nordisk shares in Q1 2023, an estimated $802K.
  • Westwood Holdings Group first reported a position in Novo Nordisk in Q1 2018 and held it in 20 quarters.
  • Westwood Holdings Group's Novo Nordisk position peaked at $2.78M in Q1 2018.
  • 1,146 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on Westwood Holdings Group's 13F filing for Q1 2023, filed 12 May 2023.